Excessive Menstrual Bleeding in Adolescents With Dengue Infection

Tangnararatchakit, Kanchana; Chuansumrit, Ampaiwan; Chaiyaratana, Wathanee; Lertwongrath, Sarapee; Gajaseeni, Narumol; Udomchaisakul, Rungnapa; O-Prasertsawat, Pratak; Yoksan, Sutee

doi:10.1097/inf.0b013e3181bf5406

Cited by 6 publications

(5 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Specific and local measures to control bleeding may also be useful, such as anterior nasal packing with hemostatic sponges for epistaxis and hormonal methods for menorrhagia. [ 50 , 188 ] Unnecessary invasive procedures should be avoided. It is important to note that plasma leakage leads to elevated hematocrit levels above the baseline value.…”

Section: Managementmentioning

confidence: 99%

Severe dengue in the intensive care unit

Tejo,

Hamasaki,

Menezes

et al. 2024

Journal of Intensive Medicine

View full text Add to dashboard Cite

Section: Managementmentioning

confidence: 99%

Severe dengue in the intensive care unit

Tejo,

Hamasaki,

Menezes

et al. 2024

Journal of Intensive Medicine

View full text Add to dashboard Cite

“…Several studies have also reported excessive menstrual bleeding in dengue-infected adolescents [12,13]. In pregnancy, dengue is associated with preterm birth and low birth weight [14].…”

Section: Dear Editormentioning

confidence: 99%

Dengue: A Brief Insight

Sultana¹,

Muhammad²,

Chowdhury³

et al. 2023

TOPHJ

View full text Add to dashboard Cite

“…Tranexamic acid, an anti-fibrinolytic agent, has been suggested in such cases, though it has not yet been formally evaluated in dengue [ 123 , 124 ]. Excessive vaginal bleeding occurred in 27 % of female adolescents in one Thai study [ 125 ] who were treated with premarin, primulute N, or oral contraceptive pills. Oral northethisterone has also been recommended in dengue-associated hypermenorrhea [ 126 ].…”

Section: Systems-based Managementmentioning

confidence: 99%

Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment

Gan

2014

Curr Treat Options Infect Dis

View full text Add to dashboard Cite

Opinion statementTreatment of dengue remains supportive in the absence of targeted antiviral therapy or approved vaccines. Responsive fluid management is key to preventing progression to shock or other severe manifestations. The dynamic natural history of dengue infection and its influence on hemodynamic homeostasis needs to be carefully considered in the planning of individualized therapy. Though largely self-limiting, the sheer burden of dengue disease on the global population will result in atypical manifestations especially in children, older adults, and comorbid patients. Management of these has not yet been systematized. The failure of recent randomized controlled trials to show utility for antiviral and immunomodulatory agents in dengue is disappointing. Vaccine candidates hold promise, but growing outbreaks require more robust, evidence-based management guidelines to inform clinicians, especially in novel epidemic situations.

show abstract

Excessive Menstrual Bleeding in Adolescents With Dengue Infection

Cited by 6 publications

References 3 publications

Severe dengue in the intensive care unit

Severe dengue in the intensive care unit

Dengue: A Brief Insight

Dengue: Moving from Current Standard of Care to State-of-the-Art Treatment

Contact Info

Product

Resources

About